Magnesium alloy, method for the production thereof and use thereof

Patent metadata

Field	Value
Publication number	US-10895000-B2
Application number	US-201314395954-A
Country	US
Kind code	B2
Filing date	Jun 20, 2013
Priority date	Jun 26, 2012
Publication date	Jan 19, 2021
Grant date	Jan 19, 2021

Abstract

A magnesium alloy, implants and method for the production thereof. The magnesium alloy includes 1.5 to 7.0% by weight Zn, 0.5 to 3.5% by weight Al, the remainder being magnesium which contains impurities, which promote electrochemical potential differences and/or the formation of precipitations and/or intermetallic phases, in a total amount of no more than 0.0063% by weight of Fe, Si, Mn, Co, Ni, Cu, Zr, Y, Sc or rare earths having the ordinal numbers 21, 57 to 71 and 89 to 103, Be, Cd, In, Sn and/or Pb as well as P.

First claim

What is claimed is:

1. A biodegradable implant formed from a magnesium alloy, the magnesium alloy comprising:
1.5 to 5.5% by weight Zn, 0.5 to 2% by weight Al, the remainder being high-purity vacuum distilled magnesium defining an alloy matrix having solid solutions of Al and/or Zn and intermetallic phases of magnesium and Al in the alloy matrix, the matrix lacking Mn as an alloying element to suppress formation of the ternary intermetallic phase FeMnSi, the magnesium alloy containing a total amount of no more than 0 0063% by weight of impurities selected from the group including Fe, Si, Mn, Co, Ni, Cu, Zr, Y, Sc, lanthanoids, actinoids, Be, Cd, In, Sn, Pb, and P, wherein the alloy content of Zn in % by weight is greater than or equal to the alloy content of Al in % by weight, wherein the magnesium alloy contains precipitations in the form of Mg 3 Zn 3 Al 2 and MgZn.

2. The implant according to claim 1 , wherein the content of Zn is 3.0 to 5.5% by weight, and the content of Al is 0.5 to 2% by weight.

3. The implant according to claim 1 , wherein individual impurities in the total sum of impurities amount to the following in % by weight: Fe<0.0005; Si<0.0005; Mn<0.0005; Co<0.0005; Ni<0.0005; Cu<0.0005; Zr<0.0003; Y<0.0003; Sc or rare earths having the ordinal numbers 21, 57 to 71 and 89 to 103 in total <0.001; Be, Cd, In, Sn and/or Pb each with <0.0003; and P<0.0002.

4. The implant according to claim 1 , wherein impurity elements Fe, Si, Mn, Co, Ni, and Cu together total no more than 0 0030% by weight.

5. The implant according to claim 4 , wherein impurity elements Fe, Si, Mn, Co, Ni, and Cu together total no more than 0 0021% by weight.

6. The implant according to claim 5 , wherein impurity elements Fe, Si, Mn, Co, Ni, and Cu together total no more than 0 0009% by weight.

7. The implant according to claim 1 , wherein the alloy has a fine-grained microstructure having a grain size of <7.5 μm, without considerable electrochemical potential differences between the individual alloy matrix phases.

8. The implant according to claim 1 , wherein the magnesium alloy contains only such precipitations which have no potential differences, or potential differences as small as possible, as compared to the alloy matrix, or which are less noble than the alloy matrix.

9. The implant according to claim 1 , wherein the precipitations have a size of ≤1 μm, and are dispersedly distributed at the grain boundaries or in the grain interior.

10. The implant according to claim 1 , wherein the mechanical asymmetry is <1.25.

11. The implant according to claim 1 , having a tensile strength of ≥300 MPa, a yield point of ≥225 MPa, and a yield ratio of <0.75, wherein the difference between the tensile strength and yield point is >100 MPa, and the mechanical asymmetry is <1.25.

12. The implant according to claim 1 , wherein the content of Zn is 3.5 to 5.5% by weight, and the content of Al is 1.0 to 2.0% by weight.

13. The implant according to claim 1 , wherein the content of Zn is 4.0 to 5.5% by weight, and the content of Al 1.5 to 2% by weight.

14. The implant according to claim 1 , wherein the alloy matrix has a fine-grained microstructure <2.5 μm, without considerable electrochemical potential differences between the individual matrix phases.

15. The implant according to claim 1 , wherein the precipitations have a size of <0.2 μm, and are dispersedly distributed at the grain boundaries or in the grain interior.

16. The implant according to claim 1 , wherein the magnesium alloy forms a body of a cardiovascular implant or osteosynthesis implant.

17. The implant according to claim 1 , wherein the content of Zn is 1.5 to 3.5% by weight.

18. The implant according to claim 1 , wherein the precipitations are dispersedly distributed at the grain boundaries or in the grain interior.

19. The implant according to claim 1 , comprising one of an endovascular implant, a stent, implants for fastening and temporarily fixing tissue implants and tissue transplantations, orthopedic implant, dental implant, and neuroimplant.

Assignees

• Biotronik Ag

Inventors

• Mueller Heinz
• Uggowitzer Peter
• Loeffler Joerg

Classifications

• C22F1/00

  Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working (apparatus for mechanical working of metal B21, B23, B24) · CPC title

• C22F1/06

  of magnesium or alloys based thereon · CPC title

• A61L27/047

  Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06 · CPC title

• A61L27/58

  Materials at least partially resorbable by the body · CPC title

• C22C23/04 Primary

  with zinc or cadmium as the next major constituent · CPC title